Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study-Reference-Cited by-同舟云学术

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study

Published:2011 Issue:3 Volume:15 Page:R123
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Critical Care

Author:

Yamakawa Kazuma,Fujimi Satoshi,Mohri Tomoyoshi,Matsuda Hiroki,Nakamori Yasushi,Hirose Tomoya,Tasaki Osamu,Ogura Hiroshi,Kuwagata Yasuyuki,Hamasaki Toshimitsu,Shimazu Takeshi

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Reference21 articles.

1. Disseminated Intravascular Coagulation in Sepsis

2. The interactions between inflammation and coagulation

3. SIRS-ASSOCIATED COAGULOPATHY AND ORGAN DYSFUNCTION IN CRITICALLY ILL PATIENTS WITH THROMBOCYTOPENIA

4. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation*

5. Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Anticoagulant Therapy in Patients with Sepsis: A Meta-Analysis of Randomized Controlled Trials;2024

2. Recombinant human soluble thrombomodulin therapy in septic DIC;Japanese Journal of Thrombosis and Hemostasis;2024

3. OPTIMAL PLASMA CONCENTRATION OF THROMBOMODULIN ALFA TO TREAT SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION;Shock;2023-06-22

4. Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy;Frontiers in Medicine;2023-06-09

5. Endothelial dysfunction and immunothrombosis in sepsis;Frontiers in Immunology;2023-04-04